Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Intel does bring some much-needed expertise to the endeavor, though it's yet to disclose to what extent it's involved, ...

Elon Musk unveiled plans for a massive chip manufacturing facility in Austin, Texas, that he said will power his "galactic" ...

The technology sector is no longer asking what artificial intelligence can do for us. It is asking what AI can do for itself.

Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 174.14M to 173.93M. This put 35.4% of the company's publicly available shares ...

The $25B initiative could redefine chip manufacturing at scale, but supply constraints and long timelines likely mean IT ...

Unpriced disaster risk lurks beneath market surfaces, urging investors to consider hazard rates in valuations and resilience ...

Elon Musk’s latest industrial gambit, called Terafab, aims to interrupt the semiconductor supply chain by building a massive $25 billion chip fabrication facility in Austin, Texas. As a joint venture ...